Ryan Fitzpatrick, CEO, MD Education- AML-ALL Focus 2023- Opening Acute Myelogenous Leukemia 1 Min Read26 Ryan Fitzpatrick, CEO, MD Education In opening the Focus Meeting 2023, Ryan Fitzpatrick, CEO, expresses gratitude to attendees and collaborators…